Blood conservation: Preoperative, perioperative, and postoperative blood management options

Brian P. Chalmers, Matthew Abdel

Research output: Contribution to journalArticle

Abstract

Perioperative blood loss during elective total joint arthroplasty (TJA) can be significant, traditionally resulting in high blood transfusion rates. However, due to the risks and costs of allogeneic blood transfusion, the focus in contemporary TJA has been on strategies to minimize perioperative blood loss. While a multimodal approach is paramount in elective TJA, three main factors have contributed dramatically to the reduced allogeneic blood transfusion rates: (1) preoperative assessment and treatment of anemia, (2) expanded use of antifibrinolytics, particularly tranexamic acid (TXA), and (3) a restrictive transfusion strategy postoperatively.

Original languageEnglish (US)
Pages (from-to)259-263
Number of pages5
JournalSeminars in Arthroplasty
Volume28
Issue number4
DOIs
StatePublished - Dec 1 2017

Fingerprint

Blood Transfusion
Arthroplasty
Joints
Tranexamic Acid
Antifibrinolytic Agents
Anemia
Costs and Cost Analysis
Therapeutics

Keywords

  • Blood conservation
  • Total hip arthroplasty (THA)
  • Total joint arthroplasty (TJA)
  • Total knee arthroplasty (TKA)
  • Tranexamic acid (TXA)

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Blood conservation : Preoperative, perioperative, and postoperative blood management options. / Chalmers, Brian P.; Abdel, Matthew.

In: Seminars in Arthroplasty, Vol. 28, No. 4, 01.12.2017, p. 259-263.

Research output: Contribution to journalArticle

@article{7bb22b595c6c47c1b52ec653fb247079,
title = "Blood conservation: Preoperative, perioperative, and postoperative blood management options",
abstract = "Perioperative blood loss during elective total joint arthroplasty (TJA) can be significant, traditionally resulting in high blood transfusion rates. However, due to the risks and costs of allogeneic blood transfusion, the focus in contemporary TJA has been on strategies to minimize perioperative blood loss. While a multimodal approach is paramount in elective TJA, three main factors have contributed dramatically to the reduced allogeneic blood transfusion rates: (1) preoperative assessment and treatment of anemia, (2) expanded use of antifibrinolytics, particularly tranexamic acid (TXA), and (3) a restrictive transfusion strategy postoperatively.",
keywords = "Blood conservation, Total hip arthroplasty (THA), Total joint arthroplasty (TJA), Total knee arthroplasty (TKA), Tranexamic acid (TXA)",
author = "Chalmers, {Brian P.} and Matthew Abdel",
year = "2017",
month = "12",
day = "1",
doi = "10.1053/j.sart.2018.02.008",
language = "English (US)",
volume = "28",
pages = "259--263",
journal = "Seminars in Arthroplasty",
issn = "1045-4527",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Blood conservation

T2 - Preoperative, perioperative, and postoperative blood management options

AU - Chalmers, Brian P.

AU - Abdel, Matthew

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Perioperative blood loss during elective total joint arthroplasty (TJA) can be significant, traditionally resulting in high blood transfusion rates. However, due to the risks and costs of allogeneic blood transfusion, the focus in contemporary TJA has been on strategies to minimize perioperative blood loss. While a multimodal approach is paramount in elective TJA, three main factors have contributed dramatically to the reduced allogeneic blood transfusion rates: (1) preoperative assessment and treatment of anemia, (2) expanded use of antifibrinolytics, particularly tranexamic acid (TXA), and (3) a restrictive transfusion strategy postoperatively.

AB - Perioperative blood loss during elective total joint arthroplasty (TJA) can be significant, traditionally resulting in high blood transfusion rates. However, due to the risks and costs of allogeneic blood transfusion, the focus in contemporary TJA has been on strategies to minimize perioperative blood loss. While a multimodal approach is paramount in elective TJA, three main factors have contributed dramatically to the reduced allogeneic blood transfusion rates: (1) preoperative assessment and treatment of anemia, (2) expanded use of antifibrinolytics, particularly tranexamic acid (TXA), and (3) a restrictive transfusion strategy postoperatively.

KW - Blood conservation

KW - Total hip arthroplasty (THA)

KW - Total joint arthroplasty (TJA)

KW - Total knee arthroplasty (TKA)

KW - Tranexamic acid (TXA)

UR - http://www.scopus.com/inward/record.url?scp=85043244335&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043244335&partnerID=8YFLogxK

U2 - 10.1053/j.sart.2018.02.008

DO - 10.1053/j.sart.2018.02.008

M3 - Article

AN - SCOPUS:85043244335

VL - 28

SP - 259

EP - 263

JO - Seminars in Arthroplasty

JF - Seminars in Arthroplasty

SN - 1045-4527

IS - 4

ER -